Abstract:Background Herpes simplex virus type 1 (HSV-1) is a ubiquitous infectious pathogen that widely affects human health. To decipher the complicated human-HSV-1 interactions, a comprehensive protein-protein interaction (PPI) network between human and HSV-1 is highly demanded. Methods To complement the experimental identification of human-HSV-1 PPIs, an integrative strategy to predict proteome-wide PPIs between human and HSV-1 was developed. For each human-HSV-1 protein pair, four popular PPI inference methods, including interolog mapping, the domain-domain interaction-based method, the domain-motif interaction-based method, and the machine learning-based method, were optimally implemented to generate four interaction probability scores, which were further integrated into a final probability score. Results As a result, a comprehensive high-confidence PPI network between human and HSV-1 was established, covering 10,432 interactions between 4,546 human proteins and 72 HSV-1 proteins. Functional and network analyses of the HSV-1 targeting proteins in the context of human interactome can recapitulate the known knowledge regarding the HSV-1 replication cycle, supporting the overall reliability of the predicted PPI network. Considering that HSV-1 infections are implicated in encephalitis and neurodegenerative diseases, we focused on exploring the biological significance of the brain-specific human-HSV-1 PPIs. In particular, the predicted interactions between HSV-1 proteins and Alzheimer’s-disease-related proteins were intensively investigated. Conclusion The current work can provide testable hypotheses to assist in the mechanistic understanding of the human-HSV-1 relationship and the anti-HSV-1 pharmaceutical target discovery. To make the predicted PPI network and the datasets freely accessible to the scientific community, a user-friendly database browser was released at http://www.zzdlab.com/HintHSV/index.php .

Adaptive Evolution Sites Virus 2 by Arginine Mutagenesis at Alpha-Defensin 5 against Herpes Simplex Enhancement of Antiviral Activity of Human

Enhancement of Antiviral Activity of Human Alpha-Defensin 5 Against Herpes Simplex Virus 2 by Arginine Mutagenesis at Adaptive Evolution Sites

Prediction and Analysis of Human-Herpes Simplex Virus Type 1 Protein-Protein Interactions by Integrating Multiple Methods

Delineation of Interfaces on Human Alpha-Defensins Critical for Human Adenovirus and Human Papillomavirus Inhibition

Key Determinants of Human α-Defensin 5 and 6 for Enhancement of HIV Infectivity.

Human α- and β-Defensins Block Multiple Steps in Herpes Simplex Virus Infection

Critical Determinants of Human Α-Defensin 5 Activity Against Non-enveloped Viruses

Recent advances in the research and development of human defensins.

Function and Mechanism of Antiviral Wasp Venom Peptide Protopolybia-MP III and Its Derivatives against HSV-1

Lead optimization to improve the antiviral potency of 2-aminobenzamide derivatives targeting HIV-1 Vif-A3G axis

In Vitro Antiviral Activity of Two Host Defense Peptides Against Human alphaherpesvirus 1

Advances in the immunoescape mechanisms exploited by alphaherpesviruses

Mechanisms of AAV2 neutralization by human alpha-defensins

Toward the Eradication of Herpes Simplex Virus: Vaccination and Beyond

Highly Active Antiretroviral Therapy 1-Infected Patients Treated with Prolonged Human Immunodeficiency Virus Type vCP 1452 and Recombinant gp 160 in Newly Safety and Immunogenicity of ALVAC

Integrating network pharmacology and experimental validation to decipher the mechanism of the Chinese herbal prescription JieZe-1 in protecting against HSV-2 infection

Ultrapotent neutralizing antibodies against SARS-CoV-2 with a high degree of mutation resistance

Two Partially Overlapping Antiviral Peptides from the External Portion of HIV Type 1 Glycoprotein 41, Adjoining the Transmembrane Region, Affect the Glycoprotein 41 Fusion Domain

Current Antivirals and Novel Botanical Molecules Interfering With Herpes Simplex Virus Infection

The Herpes Simplex Virus 2 UL21 Protein Is Essential for Virus Propagation

Intravaginal Zinc Oxide Tetrapod Nanoparticles as Novel Immunoprotective Agents against Genital Herpes